﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Sat, 04 Jul 2009 20:16:17--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/rss/news/</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2009 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Sat, 04 Jul 2009 20:16:17</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Dronedarone Approved for Atrial Arrhythmias]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3120</link><description><![CDATA[FDA today announced the approval of the oral antiarrhythmia drug dronedarone for the maintenance of normal heartbeat in certain patients with a history of paroxysmal or persistent atrial fibrillation or atrial flutter.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3120</guid><pubDate>Thu, 02 Jul 2009</pubDate></item><item><title><![CDATA[Ferumoxytol Approved for Iron Deficiency Anemia]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3119</link><description><![CDATA[AMAG Pharmaceuticals announced Tuesday that it has received FDA's approval to market ferumoxytol injection for the treatment of iron deficiency anemia in adults with chronic kidney disease.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3119</guid><pubDate>Wed, 01 Jul 2009</pubDate></item><item><title><![CDATA[Mental Health Warnings Increase for Bupropion, Varenicline]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3118</link><description><![CDATA[FDA announced today that the makers of bupropion and varenicline products must more prominently display warnings about the risk of serious mental health events occurring during therapy.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3118</guid><pubDate>Wed, 01 Jul 2009</pubDate></item><item><title><![CDATA[Theft Prompts Astellas Product Lot Withdrawal]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3117</link><description><![CDATA[Astellas Pharma US Inc. is withdrawing from the market 22 specific lots of eight products that were stolen from a transport trailer earlier this month, the company announced (PDF) yesterday.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3117</guid><pubDate>Fri, 26 Jun 2009</pubDate></item><item><title><![CDATA[Risk-Management Plan for Opioid Drugs Proves Slow Going]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3116</link><description><![CDATA[FDA officials recently acknowledged the enormity of a task that the agency set for itself in February—creating a risk evaluation and mitigation strategy, or REMS, to ensure the safe use of long-acting and extended-release opioid drugs.]]></description><category>AJHP</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3116</guid><pubDate>Fri, 26 Jun 2009</pubDate></item><item><title><![CDATA[Drug Counterfeiting Burden Remains a Guess, Experts Say]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3115</link><description><![CDATA[The proliferation of counterfeit medications is believed to be a growing problem, but experts acknowledge that a lack of solid data on the scope of counterfeiting poses obstacles to controlling it.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3115</guid><pubDate>Fri, 26 Jun 2009</pubDate></item><item><title><![CDATA[CDC Reinstates Full Hib Vaccination Schedule]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3114</link><description><![CDATA[U.S. supplies of vaccines that protect children against Haemophilus influenzae type b (Hib) disease are sufficient to reinstate the full four-dose series, the Centers for Disease Control and Prevention (CDC) announced yesterday.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3114</guid><pubDate>Fri, 26 Jun 2009</pubDate></item><item><title><![CDATA[Officials Seize 33 Generic Medications From Michigan Company]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3113</link><description><![CDATA[U.S. marshals, working with FDA personnel, yesterday seized $15&#8211;20 million worth of generic drugs and drug ingredients from three Michigan manufacturing facilities operated by Caraco Pharmaceuticals Inc., the company announced yesterday.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3113</guid><pubDate>Fri, 26 Jun 2009</pubDate></item><item><title><![CDATA[Switches of Antiepileptic Drug Products Come Under Fire]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3112</link><description><![CDATA[A patient advocacy group&#8217;s campaign and the media&#8217;s recent focus on generic drug substitution have increased the need for pharmacists to judge FDA-declared bioequivalent products by more than just price, say two pharmacists who work at epilepsy clinics.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3112</guid><pubDate>Wed, 24 Jun 2009</pubDate></item><item><title><![CDATA[FDA Approves Canakinumab for Rare Inflammatory Disorders]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3111</link><description><![CDATA[Novartis on Thursday announced the approval of canakinumab, or Ilaris, for the treatment of the cryopyrin-associated periodic syndromes (CAPS) known as familial cold autoinflammatory syndrome and Muckle-Wells syndrome in patients age four years or older.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3111</guid><pubDate>Fri, 19 Jun 2009</pubDate></item></channel></rss>